Prenetics Global (PRE) Cash & Equivalents (2021 - 2026)

Prenetics Global has disclosed Cash & Equivalents across 6 years of filings, most recently posting $56.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 29.81% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $56.0 million (up 29.81% YoY), while the FY2025 annual figure was $32.1 million, down 38.51% from the prior year.
• Cash & Equivalents climbed to $56.0 million in Q1 2026, from $32.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for PRE reached as high as $177.2 million in Q2 2023 and fell as low as $13.3 million in Q3 2025.
• The 5-year median for Cash & Equivalents is $52.3 million (2024), against an average of $73.3 million.
• Annual changes were most pronounced in 2023 — Cash & Equivalents surged 385.7% — and 2024, when it slumped 76.74%.
• A 5-year view of Cash & Equivalents shows it stood at $146.7 million in 2022, then tumbled by 68.84% to $45.7 million in 2023, then climbed by 14.32% to $52.3 million in 2024, then plunged by 38.51% to $32.1 million in 2025, then surged by 74.34% to $56.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $56.0 million, $32.1 million, and $13.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.